Literature DB >> 20163914

Gold(III) porphyrin 1a inhibited nasopharyngeal carcinoma metastasis in vivo and inhibited cell migration and invasion in vitro.

Ching Tung Lum1, Xiong Liu, Raymond Wai-Yin Sun, Xiang-Ping Li, Ying Peng, Ming-Liang He, Hsiang Fu Kung, Chi-Ming Che, Marie C M Lin.   

Abstract

A physiologically stable gold compound, gold(III) meso-tetraphenylporphyrin (gold-1a), has been shown to be effective in inducing apoptosis and prolonging the survival of hepatocellular carcinoma (HCC)-bearing rats as well as inhibiting the tumor growth of mice bearing nasopharyngeal carcinoma (NPC), neuroblastoma and colon carcinoma. In this study, we showed that gold-1a prolonged the survival of NPC metastasis-bearing mice and inhibited intrahepatic and lung metastasis. Histologically, gold-1a markedly reduced tumor microvessel formation. Consistently, in in vitro studies, gold-1a inhibited migration and invasion of C666-1 human NPC cells. The data strongly support the use of gold(III) compounds to treat cancer metastasis. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20163914     DOI: 10.1016/j.canlet.2010.01.033

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

1.  An orthotopic model of metastatic nasopharyngeal carcinoma and its application in elucidating a therapeutic target that inhibits metastasis.

Authors:  Pamela A Smith; David Merritt; Leah Barr; David A Thorley-Lawson
Journal:  Genes Cancer       Date:  2011-11

2.  A Multifunctional Hydrogel Delivers Gold Compound and Inhibits Human Lung Cancer Xenograft.

Authors:  Puiyan Lee; Chun-Nam Lok; Chi-Ming Che; Weiyuan John Kao
Journal:  Pharm Res       Date:  2019-03-08       Impact factor: 4.200

3.  Modeling nasopharyngeal carcinoma in three dimensions.

Authors:  Prabu Siva Sankar; Mohd Firdaus Che Mat; Kalaivani Muniandy; Benedict Lian Shi Xiang; Phang Su Ling; Susan Ling Ling Hoe; Alan Soo-Beng Khoo; Nethia Mohana-Kumaran
Journal:  Oncol Lett       Date:  2017-02-08       Impact factor: 2.967

4.  Novel amphiphilic cationic porphyrin and its Ag(II) complex as potential anticancer agents.

Authors:  Artak Tovmasyan; Nelli Babayan; David Poghosyan; Kristine Margaryan; Boris Harutyunyan; Rusanna Grigoryan; Natalia Sarkisyan; Ivan Spasojevic; Suren Mamyan; Lida Sahakyan; Rouben Aroutiounian; Robert Ghazaryan; Gennadi Gasparyan
Journal:  J Inorg Biochem       Date:  2014-06-27       Impact factor: 4.155

Review 5.  Development of individualized anti-metastasis strategies by engineering nanomedicines.

Authors:  Qianjun He; Shengrong Guo; Zhiyong Qian; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2015-06-09       Impact factor: 54.564

6.  Preserving charge and oxidation state of Au(III) ions in an agent-functionalized nanocrystal model system.

Authors:  Stefan Müllegger; Wolfgang Schöfberger; Mohammad Rashidi; Thomas Lengauer; Florian Klappenberger; Katharina Diller; Kamuran Kara; Johannes V Barth; Eva Rauls; Wolf Gero Schmidt; Reinhold Koch
Journal:  ACS Nano       Date:  2011-07-18       Impact factor: 15.881

7.  Water-soluble Manganese and Iron Mesotetrakis(carboxyl)porphyrin: DNA Binding, Oxidative Cleavage, and Cytotoxic Activities.

Authors:  Lei Shi; Yi-Yu Jiang; Tao Jiang; Wei Yin; Jian-Ping Yang; Man-Li Cao; Yu-Qi Fang; Hai-Yang Liu
Journal:  Molecules       Date:  2017-06-29       Impact factor: 4.411

8.  Binding of Gold(III) Porphyrin by the Pro-metastatic Regulatory Protein Human Galectin-3.

Authors:  Vanya Bogoeva; Miroslav Rangelov; Nadezhda Todorova; Annie Lambert; Clarisse Bridot; Anna Yordanova; Goedele Roos; Cyrille Grandjean; Julie Bouckaert
Journal:  Molecules       Date:  2019-12-12       Impact factor: 4.411

Review 9.  Organometallic gold(I) and gold(III) complexes for lung cancer treatment.

Authors:  Juzheng Zhang; Yanping Li; Ronghao Fang; Wei Wei; Yong Wang; Jiamin Jin; Feng Yang; Jian Chen
Journal:  Front Pharmacol       Date:  2022-09-13       Impact factor: 5.988

Review 10.  Gold-Based Medicine: A Paradigm Shift in Anti-Cancer Therapy?

Authors:  Chien Ing Yeo; Kah Kooi Ooi; Edward R T Tiekink
Journal:  Molecules       Date:  2018-06-11       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.